StockpollyBeta
Get App
Delisting riskPopularity #4,747
SNTI · NASDAQ · Biotechnology

Senti Biosciences (SNTI)

Gene-circuit developer for programmable cell and gene therapies.

$0.3299
After hours+0.01 (+1.95%)
At close$0.3236(+4.39%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue000000000000
Cost of revenue011101010101
Gross profit0−1−1−10−10−10−10−1
441715121515161517131214
Research & development99999891011858
886367676667
General & administrative800060676667
Other expenses27000101−11−10−1
Operating income−44−18−16−13−15−16−16−17−17−14−11−14
7042−141622−1−172
Interest income10000−1000000
Other non-operating income−260−4−20−160−201−70
Income before tax−37−19−12−11−29−1−14−15−18−14−4−13
Net income from continuing operations−37−19−12−11−29−1−14−15−18−14−4−13
Discontinued operations2200000000000
Net income−15−19−12−11−29−1−14−15−18−14−4−13
EPS, basic−$3.36−$4.16−$2.65−$2.45−$6.31−$0.13−$1.41−$0.56−$0.69−$0.53−$0.14−$0.41
EPS, diluted−$3.36−$4.16−$2.65−$2.45−$6.31−$0.13−$1.41−$0.56−$0.69−$0.53−$0.14−$0.41
Weighted average shares, basic455555102626223131
Weighted average shares, diluted455555102626223131
EBITDA−16−17−11−10−151−15−13−16−14−4−14
Depreciation & amortization211111111111
EBIT−18−19−12−11−15−1−16−15−17−14−4−14